Zebrafish as an Emerging Model for Sarcopenia: Considerations, Current Insights, and Future Directions
-
Published:2023-11-30
Issue:23
Volume:24
Page:17018
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Callegari Santiago1ORCID, Mirzaei Foad2ORCID, Agbaria Lila2, Shariff Sanobar2, Kantawala Burhan2, Moronge Desmond3, Ogendi Brian M. O.4ORCID
Affiliation:
1. Vascular Medicine Outcomes Laboratory, Cardiology Department, Yale University, New Haven, CT 06510, USA 2. Faculty of General Medicine, Yerevan State Medical University after Mikhtar Heratsi, 2 Koryun, Yerevan 0025, Armenia 3. Department of Physiology, Medical College of Georgia, Augusta, GA 30912, USA 4. Department of Medicine, Michigan State University College of Human Medicine, Grand Rapids, MI 49503, USA
Abstract
Sarcopenia poses a significant challenge to public health and can severely impact the quality of life of aging populations. Despite extensive efforts to study muscle degeneration using traditional animal models, there is still a lack of effective diagnostic tools, precise biomarkers, and treatments for sarcopenia. Zebrafish models have emerged as powerful tools in biomedical research, providing unique insights into age-related muscle disorders like sarcopenia. The advantages of using zebrafish models include their rapid growth outside of the embryo, optical transparency during early developmental stages, high reproductive potential, ease of husbandry, compact size, and genetic tractability. By deepening our understanding of the molecular processes underlying sarcopenia, we may develop novel diagnostic tools and effective treatments that can improve the lives of aging individuals affected by this condition. This review aims to explore the unique advantages of zebrafish as a model for sarcopenia research, highlight recent breakthroughs, outline potential avenues for future investigations, and emphasize the distinctive contributions that zebrafish models offer. Our research endeavors to contribute significantly to address the urgent need for practical solutions to reduce the impact of sarcopenia on aging populations, ultimately striving to enhance the quality of life for individuals affected by this condition.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference108 articles.
1. Bashirzade, A.A., Zabegalov, K.N., Volgin, A.D., Belova, A.S., Demin, K.A., de Abreu, M.S., Babchenko, V.Y., Bashirzade, K.A., Yenkoyan, K.B., and Tikhonova, M.A. (2022). Modeling neurodegenerative disorders in zebrafish. Neurosci. Biobehav. Rev., 138. 2. Zebrafish as a tractable model of human cardiovascular disease;Bowley;Br. J. Pharmacol.,2022 3. Zebrafish models of sarcopenia;Daya;Dis. Models Mech.,2020 4. Ichii, S., Matsuoka, I., Okazaki, F., and Shimada, Y. (2022). Zebrafish Models for Skeletal Muscle Senescence: Lessons from Cell Cultures and Rodent Models. Molecules, 27. 5. Effectiveness of zebrafish models in understanding human diseases-A review of models;Adhish;Heliyon,2023
|
|